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Samples are from African-American mothers who gave birth between Jan. 2000 
and Apr. 2007 (California Very Preterm Birth Study)²: 343 controls, 78 
preeclampsia, 330 pre-term (pre-term defined as birth at <34 weeks).  
 
Results were confirmed using gel electrophoresis. 
Figure 3. qPCR peaks positive 
and negative for deletion, 
respectively. The reaction is run 
with a dye that causes PCR 
products to fluoresce. During 
the melt stage, fluorescence is 
lost as DNA strands 
disassociate. Loss of 
fluorescence occurs at a unique 
temperature depending on 
whether or not the deletion is 
present.  
Figure 4. Maternal DNA that has 
been amplified with the 1597∆C 
primer.  
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Individuals 630 81 2 
Frequency 88.36% 11.36% 0.28% 
However, a deletion at nucleotide 1597 produces a frameshift mutation, rendering 
the HLA-G antigen unable to interact with KIR 2DL4⁵. It is speculated that this 
failed interaction might cause the mother’s immune system to allow an increased 
natural killer cell response to the fetus, aborting the pregnancy. Here we examine 
the DNA from a large population of African-American mothers to determine if this 
association between HLA-G 1597∆C is causative in pre-term birth. The African-
American population is of particular interest as this demographic has a uniquely 
high incidence of preterm birth. 
Figure 1. Premature baby  in Neonatal Intensive 
Care Unit  
disorder: preeclampsia⁴. The interaction between HLA-G antigen on trophoblasts 
and inhibitory killer-immunoglobulin like receptor (KIR) 2DL4 on natural killer cells 
produces an inhibitory effect on the natural killer cell³.  
Figure 2. Interaction of HLA-G and KIR 2DLA between trophoblast and NK cells.  
Natural killer cells are of particular 
interest during pregnancy, as they 
account for 70% of all lymphocytes in the 
placenta¹. Thus, abnormalities in  natural 
killer (NK) cells have been implicated in 
pre-term birth, the leading cause of 
infant mortality². A suggested causative 
factor is a deletion at nucleotide 1597 in 
the HLA-G gene, which codes for the 
HLA-G histocompatibility antigen. HLA-G 
is of interest as: it is a rare “non-classical” 
antigen predominantly produced by fetal 
cells³, and HLA-G polymorphisms have 
been implicated in another pregnancy  
Figure 3. HLA-G 1597∆C  deletion site. 
GAACGAGGACCTGCGCTCC  
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We are confirming the association between 1597∆C and pre-term birth in this 
population,  and a positive association would suggest that mothers possessing the 
deletion are at risk for delivering pre-term. As this is a double-blind study, we are 
unaware which genotypes correlate with pre-term birth. We are currently awaiting 
completion of the statistical analysis by the California Department of Health.  
  
 
Maternal DNA was amplified using quantitative (“real-time”) PCR (qPCR), which 
can quantify target sequences of DNA. Each sample was run twice with primers 
positive (1597∆C) and negative (HLA-G, or 1597) for the deletion. Peaks at 
approx. 88°C signified the deletion, and peaks at 77 °C (with absence of a 
positive peak) signified absence of the deletion.  
Conclusion 
